Induction of NK Activity in Murine and Human Cells by CpG Motifs in Oligodeoxynucleotides and Bacterial DNA

Journal of Immunology

Volumn 157, Issue 5, 1996, Pages 1840-1845

  Ballas, Zuhair K ^a,b,c   Rasmussen, Wendy L ^a   Krieg, Arthur M ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CYTIDYLYL 3' 5' GUANOSINE; CYTIDYLYL-3'-5'-GUANOSINE; DINUCLEOSIDE PHOSPHATE; INTERFERON; INTERLEUKIN 12; OLIGODEOXYRIBONUCLEOTIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; B LYMPHOCYTE; BAGG ALBINO MOUSE; C57BL MOUSE; CHEMISTRY; CYTOTOXICITY; DBA MOUSE; DRUG EFFECT; HUMAN; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE ACTIVATION; MOUSE; MOUSE MUTANT; NATURAL KILLER CELL; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PHYSIOLOGY; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; CYTOTOXICITY, IMMUNOLOGIC; DINUCLEOSIDE PHOSPHATES; DNA, BACTERIAL; HUMANS; INJECTIONS, INTRAPERITONEAL; INTERFERON TYPE I; INTERLEUKIN-12; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, NUDE; MICE, SCID; OLIGODEOXYRIBONUCLEOTIDES; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030239828     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Krieg, A. K., A.-K. Yi, S. Matson, T. J. Waldschmidt, G. A. Bishop, R. Teasdale, G. Koretzky, and D. Klinman. 1995. B cell activation by oligodeoxynucleotides that contain stem-loop motifs. Nature 374:546.
2. Tokunaga, T., H. Yamamoto, S. Shimada, H. Abe, T. Fukuda, Y. Fujisawa, Y. Furutani, O. Yano, T. Kataoka, T. Sudo, N. Makiguchi, and T. Suganuma. 1984. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. JNCI 72:955.
3. Yamamoto, S., E. Kuramoto, S. Shimada, and T. Tokunaga. 1988. In vitro augmentation of natural killer cell activity and production of interferon-α/β and -γ with deoxyribonucleic acid fraction from Mycobacterium bovis BCG. Jpn. J. Cancer Res. 79:866.
4. Yamamoto, S., T. Yamamoto, S. Shimada, E. Kuramoto, O. Yano, T. Kataoka, and T. Tokunaga. 1992. DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiol. Immunol. 36:983.
5. Yamamoto, S., T. Yamamoto, T. Kataoka, E. Kuramoto, O. Yano, and T. Tokunaga. 1992. Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J. Immunol. 148:4072.
6. + subset. J. Allergy Clin. Immunol. 85:4530.
7. + subset. J. Immunol. 145:1039.
8. + lymphokine-activated killer subset. J. Immunol. 150:17.
9. Kuramoto, E., O. Yano, Y. Kimura, M. Baba, T. Makino, S. Yamamoto, T. Yamamoto, T. Kataoka, and T. Tokunaga. 1992. Oligonucleotide sequences required for natural killer cell activation. Jpn. J. Cancer Res. 83:1128.
10. RC5) cells. Antisense Res. Dev. 4:211.
11. Klinman, D. M., A.-K. Yi, S. L. Beaucage, J. Conover, and A. M. Krieg. 1996. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interfere γ. Proc. Natl. Acad. Sci. USA 93: 2879.
12. Trinchieri G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251.
13. - precursors. Cell. Immunol. 134:296.
14. Koo, G. C., M. E. Jewell, C. L. Manyak, N. H Sigal, and L. S. Wicker. 1988. Activation of murine natural killer cells and macrophages by 8-bromoguanosine J. Immunol. 140:3249.
15. Thompson, R. A., and Z. K. Ballas. 1990. Lymphokine-activated killer (LAK) cells. V. 8-Mercaptoguanosine as an IL-2-sparing agent in LAK generation. J. Immunol. 145:3524.
16. Brown, M. S., S. K. Basu, J. R. Falck, and Y. K. Ho. 1980. The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. J. Supramol. Struct. 13: 67.
17. Zhao, Q., S. Matson, C. J. Herrara, E. Fisher, H. Yu, A. Waggoner, and A. M. Krieg. 1993. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides. Antisense Res. Dev. 3:53.
18. Stein, C. A., and Y.-C. Cheng. 1993. Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science 261:1004.
19. Yaswen, P., M. R. Stampfer, K. Ghosh, and J. S. Cohen. 1993. Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells. Antisense Res. Dev. 3:67.
20. Halpern, M. D., and D. S. Pisetsky. 1995. In vitro inhibition of murine IFNγ production by phosphorothioate deoxyguanosine oligomers. Immunopharmacology 29:47.